Pharmaceuticals and Biotechnology Option and Evaluation Deals Report 2023: Comprehensive Details of Actual Deals Signed Since 2016
The “Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter option and evaluation deals. Fully revised and…
Lipocine to Present at the Cantor Fitzgerald Global Healthcare Conference
Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (CNS) disorders, today announced that Dr. Mahesh Patel, President and Chief Executive Officer, will present and meet with investors at the 2023 Cantor Fitzgerald Global Healthcare Conference…
Citius Pharmaceuticals to Participate in H.C. Wainwright and Sidoti Investor Conferences in September 2023
Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced its participation in two investor conferences in September 2023. Citius Chairman and CEO Leonard…
Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the H.C. Wainwright Global Investment Conference in New York City on Wednesday, September 13, 2023. A corporate presentation is scheduled for 4:00 p.m. Eastern Time. The…
LOTTE BIOLOGICS Holds ‘ESG Declaration Ceremony’
LOTTE BIOLOGICS is embarking on full-fledged ESG (Environmental, Social, and Governance) management. On August 30, LOTTE BIOLOGICS, under the leadership of CEO Richard Lee, held its ‘ESG Declaration Ceremony’ at the Executive Briefing Center (EBC) on the 113th floor of…
WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturing Line at Wuxi City Site
WuXi STA, a renowned Contract Research, Development, and Manufacturing Organization (CRDMO), made a groundbreaking announcement recently. The company has initiated a high potency, fully automated sterile injectable manufacturing line at its Wuxi City site, upping its manufacturing capabilities and capacity…
CPHI & PMEC China 2023 to launch international roadshow in Guangzhou
In an affirmation of South China’s booming pharmaceutical industry, CPHI & PMEC China is set to host an exclusive roadshow at the PWTC Expo in Guangzhou, Guangdong Province. Slated for 4-6 September, 2023, this comes right after the record-breaking success…
VENUS REMEDIES BAGS APPROVAL TO MARKET MEROPENEM, ITS BLOCKBUSTER GENERIC DRUG, IN SPAIN
The pharmaceutical world is abuzz as Venus Remedies Limited secures marketing authorization for meropenem in Spain. A leader in research-based pharmaceuticals, Venus Remedies is setting new benchmarks in healthcare. Meropenem, part of the carbapenem class of antibiotics, is known for…
